Showing results (61-70 of 91) with videos related to
Sort By:
Pageof 10
Pathology Oncology Research : POR|June 20, 2020
A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell CarcinomaGuocheng Huang, Xinji Li, Zebo Chen, et al.Journal of Clinical Laboratory Analysis|November 28, 2020
miR-30b-5p up-regulation related to the dismal prognosis for patients with renal cell cancerChunduo Zhang, Xiang Pan, Xiqi Peng, et al.The International Journal of Biological Markers|August 6, 2019
miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgeryXiqi Peng, Xiang Pan, Kaihao Liu, et al.Pathology, Research and Practice|May 12, 2019
Associations of high expression of miR-106b-5p detected from FFPE sample with poor prognosis of RCC patientsKaihao Liu, Xiang Pan, Xiqi Peng, et al.Cell Cycle (Georgetown, Tex.)|May 28, 2021
miR-451 suppresses EMT and metastasis in glioma cellsYang Nan, Liyun Guo, Yalin Lu, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 1, 2018
miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinomaXiang Pan, Jing Quan, Zuwei Li, et al.Oncology Reports|August 23, 2018
microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosisXiang Pan, Zuwei Li, Liwen Zhao, et al.World Journal of Surgical Oncology|July 22, 2025
ALOXE3 expression predicts poor prognosis and modulates immune infiltration in colon adenocarcinomaLiwen Zhao, Liya Zhao, Siyu Ye, et al.American Journal of Translational Research|July 19, 2018
Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCCLiang Zhou, Zuwei Li, Xiang Pan, et al.Scientific Reports|February 18, 2025
Comprehensive analysis of CLEC family genes in gastric cancer prognosis immune response and treatmentWeijian Zhu, Qiang Yi, Jiaqi Wang, et al.Pageof 10